C-POLAR Biotech
Research - , Kowloon, Hong Kong
C-POLAR Biotech Employees
C-POLAR Biotech Details
An advanced development and manufacturing of bioelectret company for electroceuticalsC-Polar Biotech Limited is an advanced development and manufacturing of bioelectret company for electroceuticals, which has developed our own C-Polar bioelectret to arrest, inactivate and eliminate high ratios of microbiome, including coronavirus, influenza and coxsackievirus, from fast air flow, with short contact time only.Our mechanism is independent from external energy, chemical consumption, and toxicity to human cells. To protect C-Polar's partners, our mechanism is patented in Hong Kong and United Stated, covering 158 countries and regions globally.C-Polar has a clear ability to:- Arrest 99.9% SARS-229E and Coxsackievirus B6- Inactivate 99.9% SARS-229E and Coxsackievirus B6 in 5 mins- Given that SARS-229E and Coxsackievirus B6 are structurally quite different, there is a high likelihood of seeing similar results with other viruses as well.- Eliminate 98% SARS-CoV-2 in 5 mins and 99.6% SARS-CoV-2 in 30 mins- No cytotoxicity to human lung cells and green monkey kidney cells- No reduction on cell sensitivity
C-POLAR Biotech Technologies
Email Providers
Gmail
Load Balancers
Varnish
CMS
Wix
Other
Mobile Friendly
Hosting
Google Cloud Hosting